Opioid analgesics are the mainstay of treatment of moderate and severe pain. Remifentanil is an ultrashort acting opioid analgesic used in emergency department (ED)procedural sedation, whereas buprenorphine/naloxone (Suboxone) is an opioid agonist-antagonist combination used in the treatment of addiction-prone individuals. We report here a case of buprenorphine/naloxone inhibition of remifentanil analgesia in a patient undergoing ED procedural sedation.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ajem.2011.07.024 | DOI Listing |
Publication Analysis
Top Keywords
buprenorphine/naloxone inhibition
8
inhibition remifentanil
8
procedural sedation
8
remifentanil procedural
4
sedation opioid
4
opioid analgesics
4
analgesics mainstay
4
mainstay treatment
4
treatment moderate
4
moderate severe
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!